Back to search

Article

eEF2K knockdown synergizes STS to inhibit the angiogenesis of lung adenocarcinoma via TG2/IL-6/VEGFR2 pathway

2022-07-06

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is the most popular type of lung cancer. Eukaryotic elongation factor 2 kinase (eEF2K) is considered to be a carcinogen, and Sulfotanshinone IIA sodium (STS) has been proved to have anticancer effect. However, their role in LUAD and its underlying mechanism remains unclear. <h4>Objective: </h4> To figuring out the roles of eEF2K and STS in angiogenesis of LUAD and t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b7db78b8-5d03-5ee8-b9ba-c661e1bbe749
DOI
10.21203/rs.3.rs-1806907/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
eEF2K knockdown synergizes STS to inhibit the angiogenesis of lung adenocarcinoma via TG2/IL-6/VEGFR2 pathwayDOI 10.21203/rs.3.rs-1806907/v1
Select a neighboring publication to make it the new centre.